Product Information
PHENOHYTRO TABLET is a generic product labeled by Winder Laboratories LLC, priced at $1.2548 per EA under NDC 75826011810. Its NADAC has been published 79 times since Jul 17, 2024.
PHENOHYTRO TABLET
PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDEStrength
.0194; .1037; 16.2; .0065 mg/1; mg/1; mg/1; mg/1
Manufacturer
Winder Laboratories LLCNDC
75826011810
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
1/22/2025
Approval Type
Unapproved
On Market Since
2/29/2016
Pharmacological Classes
Price Statistics
The NADAC for PHENOHYTRO TABLET has been published 79 times since Jul 17, 2024, and over the history we have for it it has risen 6.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2548 per EA |
|---|---|
| All-time high | $1.2548 (Jan 14, 2026) |
| All-time low | $1.1817 (Jul 17, 2024) |
| 52-week high | $1.2548 |
| 52-week low | $1.2548 |
| Median price | $1.2548 |
| Average price | $1.2391 |
| Largest weekly change | +3.3% (Oct 23, 2024) |
| Weeks tracked | 79 |
| Tracking since | Jul 17, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
0.0%
3Y
N/A
5Y
N/A
All
+6.2%
Last surveyed Jan 14, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Winder Laboratories LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PHENOHYTRO TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PHENOHYTRO TABLET, manufactured by Winder Laboratories LLC, is $1.2548 per EA (NDC 75826011810), effective Jan 14, 2026.
How has the price of PHENOHYTRO TABLET changed over time?
Over the history we have for it, the NADAC for PHENOHYTRO TABLET has risen 6.2%. It has been tracked across 79 weekly CMS publications since Jul 17, 2024.
What are the highest and lowest recorded NADAC prices for PHENOHYTRO TABLET?
Since Jul 17, 2024, the NADAC for PHENOHYTRO TABLET has ranged from a low of $1.1817 (Jul 17, 2024) to a high of $1.2548 (Jan 14, 2026), with a median of $1.2548 per EA.
Are there cheaper alternatives to PHENOHYTRO TABLET?
No other NADAC-published product currently shares the active ingredient and strength of PHENOHYTRO TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PHENOHYTRO TABLET?
PHENOHYTRO TABLET (NDC 75826011810) is labeled by Winder Laboratories LLC, and CMS classifies it as a generic product.